SYNOVUS FINANCIAL CORP – Halozyme Therapeutics, Inc. Transaction History
SYNOVUS FINANCIAL CORP portfolio value:
$3.04M
portfolio value
SYNOVUS FINANCIAL CORP quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +43.70% | 23.39K shares | 691K | $39.54 | 76.91K |
| Q2 2022 | share | Decrease | -31.01% | -24.05K shares | -750K | $44 | 53.52K |
| Q1 2022 | share | Increase | +11.52% | 8.01K shares | 302K | $39.88 | 77.58K |
| Q4 2021 | share | Increase | +13.30% | 8.16K shares | 302K | $40.32 | 69.56K |
| Q3 2021 | share | Increase | +19.88% | 10.18K shares | 171K | $40.68 | 61.4K |
| Q2 2021 | share | Increase | +4.07% | 2.00K shares | 268K | $45.41 | 51.21K |
| Q1 2021 | share | Decrease | -3.53% | -1.80K shares | -116K | $41.69 | 49.21K |
| Q4 2020 | share | Decrease | -13.90% | -8.23K shares | 617K | $42.71 | 51.02K |
| Q3 2020 | share | Increase | +17.70% | 8.91K shares | 205K | $26.28 | 59.26K |
| Q2 2020 | share | Decrease | -19.60% | -12.27K shares | 226K | $26.81 | 50.34K |
| Q1 2020 | share | Increase | +3.34% | 2.02K shares | 41K | $17.99 | 62.61K |
| Q4 2019 | share | Increase | +3.76% | 2.19K shares | 185K | $17.73 | 60.59K |
| Q3 2019 | share | Increase | +4.24% | 2.37K shares | -67K | $15.51 | 58.40K |
| Q2 2019 | share | Increase | +4.64% | 2.48K shares | 103K | $17.18 | 56.02K |
| Q1 2019 | share | Increase | +11.73% | 5.62K shares | 160K | $16.1 | 53.54K |
| Q4 2018 | share | Increase | +37.11% | 12.97K shares | 70K | $14.63 | 47.92K |
| Q3 2018 | share | Increase | +5.31% | 1.76K shares | 72K | $18.17 | 34.95K |
| Q2 2018 | share | Decrease | -17.47% | -7.02K shares | -227K | $16.87 | 33.19K |
| Q1 2018 | share | Increase | +5.57% | 2.12K shares | 14K | $19.59 | 40.21K |
| Q4 2017 | share | Decrease | -0.79% | -305 shares | 109K | $20.26 | 38.09K |
| Q3 2017 | share | Increase | +6.21% | 2.24K shares | 201K | $17.37 | 38.40K |
| Q2 2017 | share | Increase | +41.46% | 10.59K shares | 129K | $12.82 | 36.15K |
| Q1 2017 | share | Increase | +31.18% | 6.07K shares | 143K | $12.96 | 25.56K |
| Q4 2016 | share | Decrease | -13.62% | -3.07K shares | -81K | $9.88 | 19.48K |
| Q3 2016 | share | Increase | 0.00% | 22.55K shares | 272K | $12.08 | 22.55K |